Intact Genomics CEO, Dr. Chengcang Charles Wu was invited to speak about FAC technology at Functional Metagenomics 2016 in Inderøy, Norway, September 25-28, 2016.

On August 29, 2016, The Centers for Disease Control and Prevention/ National Center for Emerging and Zoonotic Infectious Diseases awarded Intact Genomics a Small Business Innovation Research (SBIR) Phase I contract grant. The intent of this study is to develop the techniques and enzyme reagents for 100kb single molecule sequencing with an existing sequence platform and to enable gold-standard genomic assembly of all pathogen-vector arthropod large/complex genomes with low cost.

On July 12, 2016, The National Institute of Health awarded Intact Genomics a Small Business Innovation Research (SBIR) second Phase II grant to further develop the patent-pending fungal artificial chromosome (FAC) technology. The new study’s intent is to activate silent and cryptic fungal biosynthetic gene clusters for natural product discovery by a superior ‘FAC recombineering and transgenic animal-like’ system in Aspergillus nidulans.

Intact Genomics presented at the 10th International Conference on Genomics (iCG-10).
Intact Genomics presented “New technology translates whole genome sequence information into the secondary metabolome in filamentous fungi” at the 10th International Conference on Genomics from October 22-15, 2015 in Shenzhen, China.

Intact Genomics was selected for a showcase booth and presented at the TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference on May 22-25, 2016 in Washington, D.C.

Intact Genomics presented at The 11th Annual JGI user meeting- Genomics of Energy & Environment Meeting on March 21-24 in Walnut Creek, California

Intact Genomics presented at the Startup Connection’15 Venture Showcase in St. Louis on November 18, 2015.